Description
JAINEX AAMCOL LTD. announces rights issue offering 1 equity share for every 2 shares held at Rs 120 per share (Rs 10 face value + Rs 110 premium) with record date November 20, 2025.
Summary
JAINEX AAMCOL LTD. (BSE Code: 505212) has set November 20, 2025 as the record date for its rights issue of equity shares. The company is offering 1 new equity share of Rs 10 face value at a premium of Rs 110 per share (total Rs 120) for every 2 existing equity shares held. Trading in the company’s shares will be conducted on an ex-rights basis from November 20, 2025 under settlement number DR-760/2025-2026.
Key Points
- Company: JAINEX AAMCOL LTD. (BSE Code: 505212)
- Rights ratio: 1 new share for every 2 existing shares held
- Issue price: Rs 120 per share (Rs 10 face value + Rs 110 premium)
- Record date: November 20, 2025
- Ex-rights trading begins: November 20, 2025
- Settlement number: DR-760/2025-2026
- Segment: Dematerialized Securities - Rolling Settlement
Regulatory Changes
No regulatory changes announced. This is a standard corporate action notification.
Compliance Requirements
- Trading members must execute all transactions in JAINEX AAMCOL LTD. equity shares on an ex-rights basis from November 20, 2025
- Members must note the record date for determining rights entitlement
- Transactions must comply with the dematerialized rolling settlement framework
Important Dates
- November 17, 2025: Circular issue date
- November 20, 2025: Record date for rights issue eligibility
- November 20, 2025: Ex-rights trading commences
- Settlement DR-760/2025-2026: Applicable settlement period
Impact Assessment
Shareholder Impact: Existing shareholders will receive rights to subscribe to 1 new share for every 2 shares held at Rs 120 per share. Shareholders who do not participate will face dilution of their ownership stake.
Market Impact: Limited to JAINEX AAMCOL LTD. shareholders. The ex-rights trading will adjust share price to reflect the value transfer from the rights offer. The 1:2 ratio at Rs 120 premium represents moderate capital raising activity.
Trading Impact: From November 20, 2025, all trades must be executed on ex-rights basis, meaning buyers will not be entitled to the rights issue for shares purchased on or after this date.
Impact Justification
Standard rights issue announcement affecting existing shareholders with dilution implications. Medium impact limited to company shareholders with straightforward 1:2 ratio.